Jeff D. Goldberg - 30 Jun 2026 Form 4 Insider Report for Modular Medical, Inc. (MODD)

Reporting relationship: Director
Issuer ticker: MODD
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2026, 16:31:05 UTC
Prior SEC filing: 19 May 2026
Source filing: View source filing
Reporting owner signature: /s/ James Sullivan, Attorney in Fact for Jeff D. Goldberg

Key filing fact

Jeff D. Goldberg filed Form 4 for Modular Medical, Inc. (MODD) on 02 Jul 2026.

Key facts

This page summarizes Jeff D. Goldberg's Form 4 filing for Modular Medical, Inc. (MODD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Jul 2026, 16:31.

Change

Previous filing in this sequence was filed on 19 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002001351 Primary reporting owner

Goldberg Jeff D

Relationship: Director
Address: C/O MODULAR MEDICAL, INC., 10740 THORNMINT ROAD, SAN DIEGO
Signature: /s/ James Sullivan, Attorney in Fact for Jeff D. Goldberg
Signature date: 02 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MODD transaction Derivative

Option to purchase common stock

Award

Transaction value
Shares: +250
Change %
Price
Shares after: 250
Date: 30 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 250
Exercise price: $4.88
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

Footnote F2

In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."